Clinical trial
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
NCT00538304 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- May 31, 2008
- Enrollment
- 222 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.